Publishing research using ab77077? Please let us know so that we can cite the reference in this datasheet.
ab77077 has been referenced in 4 publications.
- Smith JP et al. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207 (2018). ICC/IF . PubMed: 29043413
- Smith JP et al. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. Pancreas 43:1050-9 (2014). PubMed: 25058882
- Xu L et al. Heterobivalent ligands target cell-surface receptor combinations in vivo. Proc Natl Acad Sci U S A : (2012). IHC-Fr . PubMed: 23236171
- Berna MJ et al. CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production. J Biol Chem 285:38905-14 (2010). ICC/IF ; Rat . PubMed: 20843811